Motor neurone disease - riluzole
Description
NICE has recommended that riluzole should be available for the treatment of individuals with MND in accordance with its licensed indications. Treatment with riluzole should only be started by a neurological specialist who is experienced in the management of MND. Routine supervision of therapy may ...
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA20
Issued: January 2001
How this guidance was produced
